RxDoctor Payments Data

Mark Thompson, DO

Therapeutic Radiology · Lake City, FLNPI 1487646030

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.2% of the total across 769 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 60 manufacturers, the largest accounting for just 7.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $3,514 and has fallen 90.7% since, to $328 in 2025.

$15,074in general payments, 2019–2025

Across 769 payments — averaging $19.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Merck$975
  • Novartis$892
  • Seagen Inc.$747
  • E.r. Squibb & Sons, L.L.C.$681
  • Pfizer$647
  • plus $10K from 54 others

What the payments were for

  • Food & beverage$14,80098%
  • Education$2742%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)56$1,184
Merck50$975
Novartis56$892
Seagen Inc.37$747
E.r. Squibb & Sons, L.L.C.40$681
Pfizer34$647
Amgen(2 entities)31$554
Johnson & Johnson(2 entities)33$554
Eisai Inc.25$498
Incyte Corporation27$496
Bayer28$492
Astellas Pharma US Inc22$479
Lilly USA, LLC20$387
Bristol Myers Squibb20$378
Myriad Genetic Laboratories, Inc.17$373
Daiichi Sankyo Inc.18$364
Takeda Pharmaceuticals U.S.A., Inc.15$352
Sanofi18$322
GSK15$280
Octapharma USA, Inc.8$277
Exelixis Inc.13$247
Servier Pharmaceuticals LLC12$221
Regeneron Healthcare Solutions, Inc.11$219
Dendreon Pharmaceuticals LLC5$208
EMD Serono, Inc.8$207
AbbVie12$200
Siemens Medical Solutions USA, Inc.3$193
Genentech USA, Inc.9$167
Ipsen Biopharmaceuticals, Inc8$150
Rigel Pharmaceuticals, Inc.3$127
Blue Earth Diagnostics5$118
Integra Lifesciences Corporation1$112
Pharmacyclics LLC, An Abbvie Company7$105
Stemline Therapeutics Inc.4$96
Blueprint Medicines Corporation5$91
G1 Therapeutics, Inc.5$85
Taiho Oncology, Inc.4$85
Boehringer Ingelheim4$84
Sun Pharmaceutical Industries Inc.4$72
Dova Pharmaceuticals4$64
Sumitomo Pharma America, Inc.4$64
AVEO Pharmaceuticals, Inc.2$64
Beigene USA, Inc.2$63
Puma Biotechnology, Inc.4$61
Sobi, Inc2$61
Adaptive Biotechnologies Corporation4$59
Pharmacosmos Therapeutics Inc.3$58
Tesaro, Inc.3$56
Array Biopharma Inc3$54
Teva Pharmaceuticals USA, Inc.4$52
Verity Pharmaceuticals Inc.3$50
Jazz Pharmaceuticals Inc.3$48
Elekta, Inc.1$44
Global Blood Therapeutics, Inc.3$42
Agios Pharmaceuticals, Inc.2$40
Aurobindo Pharma USA, Inc.3$40
Reflexion Medical, Inc.1$38
Pharmaessentia USA Corporation2$35
Myovant Sciences Inc.2$29
Helsinn Therapeutics (U.S.), Inc.2$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few therapeutic radiology providers in Floridato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$1,580,006
Medicare patients
266
Services billed
7,987

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen39$1,110
Tamsulosin Hcl35$348
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$313
Oxycodone Hcl13$281

Paid to pharmacies, not to this prescriber.

Other therapeutic radiology in Lake City

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →